BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22244520)

  • 1. Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
    Tanaka Y; Matsumoto I; Iwanami K; Inoue A; Umeda N; Tanaka Y; Sugihara M; Hayashi T; Ito S; Sumida T
    Clin Exp Rheumatol; 2012; 30(1):99-102. PubMed ID: 22244520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and functional significance of STEAP4-splice variant in CD14
    Ebe H; Matsumoto I; Kawaguchi H; Kurata I; Tanaka Y; Inoue A; Kondo Y; Tsuboi H; Sumida T
    Clin Exp Immunol; 2018 Mar; 191(3):338-348. PubMed ID: 29080328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis.
    Tanaka Y; Matsumoto I; Iwanami K; Inoue A; Minami R; Umeda N; Kanamori A; Ochiai N; Miyazawa K; Sugihara M; Hayashi T; Goto D; Ito S; Sumida T
    Mod Rheumatol; 2012 Feb; 22(1):128-36. PubMed ID: 21633911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
    Inoue A; Matsumoto I; Tanaka Y; Iwanami K; Kanamori A; Ochiai N; Goto D; Ito S; Sumida T
    Arthritis Res Ther; 2009; 11(4):R118. PubMed ID: 19660107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
    Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
    Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils of rheumatoid arthritis patients on anti-TNF-α therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels.
    Dominical VM; Bértolo MB; Almeida CB; Garrido VT; Miguel LI; Costa FF; Conran N
    Scand J Immunol; 2011 Apr; 73(4):309-18. PubMed ID: 21208248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
    Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
    Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.
    Kirino Y; Takeno M; Murakami S; Kobayashi M; Kobayashi H; Miura K; Ideguchi H; Ohno S; Ueda A; Ishigatsubo Y
    Arthritis Rheum; 2007 Feb; 56(2):464-75. PubMed ID: 17265482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of STEAP4, a highly-expressed TNF-alpha-inducible gene in adipose tissue, is associated with obesity in humans.
    Zhang CM; Chi X; Wang B; Zhang M; Ni YH; Chen RH; Li XN; Guo XR
    Acta Pharmacol Sin; 2008 May; 29(5):587-92. PubMed ID: 18430367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
    Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
    Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
    Meusch U; Rossol M; Baerwald C; Hauschildt S; Wagner U
    Arthritis Rheum; 2009 Sep; 60(9):2612-21. PubMed ID: 19714631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
    Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
    Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis.
    Matsumoto T; Kaneko T; Seto M; Wada H; Kobayashi T; Nakatani K; Tonomura H; Tono Y; Ohyabu M; Nobori T; Shiku H; Sudo A; Uchida A; Kurosawa DJ; Kurosawa S
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):186-92. PubMed ID: 18372277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.
    Toh ML; Marotte H; Blond JL; Jhumka U; Eljaafari A; Mougin B; Miossec P
    Arthritis Rheum; 2006 Jul; 54(7):2109-18. PubMed ID: 16802346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
    Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
    Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL; Valesini G
    BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
    Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
    Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.
    Wijngaarden S; van de Winkel JG; Bijlsma JW; Lafeber FP; van Roon JA
    Clin Exp Rheumatol; 2008; 26(1):89-95. PubMed ID: 18328152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
    Inoue A; Matsumoto I; Tanaka Y; Umeda N; Takai C; Kawaguchi H; Ebe H; Yoshida H; Matsumoto Y; Segawa S; Takahashi S; Sumida T
    Sci Rep; 2016 Dec; 6():38684. PubMed ID: 27995997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.